Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Hydrazinophthalazine derivatives and diuretics Hydrazinophthalazine derivatives and diuretics
Hydrazinophthalazine derivatives and diuretics and its peer markets - E-Clinical Trial Solutions,
Upcoming
Alkaloids, excl. rauwolfia, in combination with diuretics Alkaloids, excl. rauwolfia, in combination with diuretics
Alkaloids, excl. rauwolfia, in combination with diuretics and its peer markets - Methyldopa and diuretics in combination,
Upcoming
MAO inhibitors and diuretics MAO inhibitors and diuretics
MAO inhibitors and diuretics and its peer markets - Chromatography,
Upcoming
Serotonin antagonists and diuretics Serotonin antagonists and diuretics
Serotonin antagonists and diuretics and its peer markets - Other antihypertensives and diuretics,
Upcoming
Thiazides, plain Thiazides, plain
Thiazides, plain and its peer markets - Immunoassay, E-Clinical...
Upcoming
Thiazides and potassium in combination Thiazides and potassium in combination
Thiazides and potassium in combination and its peer markets - Chromatography Instruments,
Upcoming
Thiazides, combinations with psycholeptics and/or analgesics Thiazides, combinations with psycholeptics and/or analgesics
Thiazides, combinations with psycholeptics and/or analgesics and its peer markets - Thiazides and potassium in combination,
Upcoming
Thiazides, combinations with other drugs Thiazides, combinations with other drugs
Thiazides, combinations with other drugs and its peer markets - Next Generation Sequencing (NGS),
Upcoming
Sulfonamides, plain Sulfonamides, plain
Sulfonamides, plain and its peer markets - Sulfonamides and potassium in combination,
Upcoming
Sulfonamides and potassium in combination Sulfonamides and potassium in combination
Sulfonamides and potassium in combination and its peer markets - E-Clinical Trial Solutions,
Upcoming
Mercurial diuretics Mercurial diuretics
Mercurial diuretics and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Xanthine derivatives Xanthine derivatives
Xanthine derivatives and its peer markets - Immunoassay,
Upcoming
Sulfonamides, combinations with other drugs Sulfonamides, combinations with other drugs
Sulfonamides, combinations with other drugs and its peer markets - Wireless Health,
Upcoming
Aryloxyacetic acid derivatives Aryloxyacetic acid derivatives
Aryloxyacetic acid derivatives and its peer markets - Chromatography Instruments,
Upcoming
Pyrazolone derivatives Pyrazolone derivatives
Pyrazolone derivatives and its peer markets - E-Clinical Trial Solutions,
Upcoming
High-ceiling sulfonamides High-ceiling sulfonamides
High-ceiling sulfonamides and its peer markets - Healthcare IT outsourcing,
Upcoming
High-ceiling Sulfonamides and potassium in combination High-ceiling Sulfonamides and potassium in combination
High-ceiling Sulfonamides and potassium in combination and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Aldosterone antagonists Aldosterone antagonists
Aldosterone antagonists and its peer markets - Digital Pathology,
Upcoming
Low-ceiling diuretics and potassium-sparing agents Low-ceiling diuretics and potassium-sparing agents
Low-ceiling diuretics and potassium-sparing agents and its peer markets - Chromatography Instruments,
Upcoming
High-ceiling diuretics and potassium-sparing agents High-ceiling diuretics and potassium-sparing agents
High-ceiling diuretics and potassium-sparing agents and its peer markets - Next Generation Sequencing (NGS),
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539